First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerLeora Horn, Stephen V. Liu, Ariel López-Chávez et al.|New England Journal of Medicine|2018Cited by 3.5k
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Stephen V. Liu, Leora Horn, Martin Reck et al.|Journal of Clinical Oncology|2021Cited by 818
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancerGeoffrey R. Oxnard, Myung‐Ju Ahn, J.C.-H. Yang et al.|Annals of Oncology|2020Cited by 443
Immunotherapeutic approaches for small-cell lung cancerWade T. Iams, Leora Horn, Jason Porter|Nature Reviews Clinical Oncology|2020Cited by 346
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung CancerLeora Horn, Christine M. Lovly, Jennifer G. Whisenant et al.|Journal of Thoracic Oncology|2019Cited by 163